Durin Life Sciences, Inc.

Amendment
CIK: 0001797306·Biotechnology·DELAWARE·Filed: Jul 21, 2025
Total Offering

$10,000,000

Amount Sold

$6,200,000

Investors

2

First Sale

Oct 17, 2023

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Maribeth Bluyus
Related Person
Robert Nagele
Related Person
Rene Chaze
Related Person

Company

Durin Life Sciences, Inc.

2 MEDICAL CENTER DR #213A

STRATFORD, NJ, 08084

877-387-4657

SEC Filing

0001797306-25-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Durin Life Sciences, Inc. Form D Filing — $10,000,000 | FilingFlow